Breaking News Instant updates and real-time market news.

BRP

BRP Group

$36.99 /

-1.01 (-2.66%)

07:54
10/28/21
10/28
07:54
10/28/21
07:54

BRP Group initiated with an Equal Weight at Morgan Stanley

Morgan Stanley analyst Michael Phillips initiated coverage of BRP Group with an Equal Weight rating and $43 price target. While he expects BRP to continue its "industry-leading" growth over the near-term, strong growth for brokers like BRP is fueling record high multiples, which he sees limiting upside. He thinks the current valuation reflects expectations of continued growth outperformance and "seems fair," Phillips added.

  • 08

    Nov

  • 09

    Dec

  • 15

    Sep

BRP BRP Group
$36.99 /

-1.01 (-2.66%)

09/16/21 Wells Fargo
BRP Group price target raised to $39 from $34 at Wells Fargo
05/24/21 JPMorgan
BRP Group price target lowered to $30 from $33 at JPMorgan
01/13/21 BofA
BRP Group reinitiated with a Neutral at BofA
11/09/20 Wells Fargo
BRP Group price target raised to $33 from $24 at Wells Fargo

TODAY'S FREE FLY STORIES

Recommendations
Ambarella price target raised to $200 from $125 at Baird » 06:59
12/01/21
12/01
06:59
12/01/21
06:59
AMBA

Ambarella

$180.08 /

-1.835 (-1.01%)

Baird analyst Tristan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

06:54 Today Deutsche Bank
Ambarella price target raised to $155 from $115 at Deutsche Bank
11/29/21 Morgan Stanley
Ambarella price target raised to $222 from $137 at Morgan Stanley
10/27/21 Needham
Ambarella price target raised to $220 from $140 at Needham
10/27/21 Roth Capital
Ambarella price target raised to $225 from $170 at Roth Capital
AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

Recommendations
Zscaler price target raised to $400 from $325 at Wolfe Research » 06:59
12/01/21
12/01
06:59
12/01/21
06:59
ZS

Zscaler

$347.02 /

-8.795 (-2.47%)

Wolfe Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

06:55 Today Deutsche Bank
Zscaler price target raised to $430 from $400 at Deutsche Bank
06:49 Today UBS
Zscaler price target raised to $380 from $295 at UBS
06:47 Today Mizuho
Zscaler price target raised to $400 from $385 at Mizuho
06:30 Today BTIG
Zscaler price target raised to $439 from $401 at BTIG
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

Recommendations
Kimco Realty price target raised to $24 from $23 at Baird » 06:58
12/01/21
12/01
06:58
12/01/21
06:58
KIM

Kimco Realty

$22.43 /

-0.85 (-3.65%)

Baird analyst Wesley…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KIM Kimco Realty
$22.43 /

-0.85 (-3.65%)

KIM Kimco Realty
$22.43 /

-0.85 (-3.65%)

11/22/21 Evercore ISI
Kimco Realty upgraded to Outperform from In Line at Evercore ISI
11/22/21 Stifel
Kimco Realty upgraded to Buy from Hold at Stifel
09/23/21 Wolfe Research
Kimco Realty initiated with a Peer Perform at Wolfe Research
09/23/21 Wolfe Research
Kimco Realty initiated with a Peer Perform at Wolfe Research
KIM Kimco Realty
$22.43 /

-0.85 (-3.65%)

Earnings
Build-A-Bear reports Q3 adjusted EPS 38c, one estimate (17c) » 06:58
12/01/21
12/01
06:58
12/01/21
06:58
BBW

Build-A-Bear

$17.01 /

-0.02 (-0.12%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BBW Build-A-Bear
$17.01 /

-0.02 (-0.12%)

BBW Build-A-Bear
$17.01 /

-0.02 (-0.12%)

BBW Build-A-Bear
$17.01 /

-0.02 (-0.12%)

Recommendations
Latham Group price target raised to $26 from $25 at Baird » 06:56
12/01/21
12/01
06:56
12/01/21
06:56
SWIM

Latham Group

$25.76 /

+2.3 (+9.80%)

Baird analyst Timothy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SWIM Latham Group
$25.76 /

+2.3 (+9.80%)

SWIM Latham Group
$25.76 /

+2.3 (+9.80%)

05:58 Today Barclays
Latham Group price target raised to $30 from $26 at Barclays
11/11/21 BofA
Latham Group upgraded to Buy from Neutral at BofA
11/11/21 Barclays
Latham Group price target raised to $26 from $23 at Barclays
11/08/21 BofA
Latham Group initiated with a Neutral at BofA
SWIM Latham Group
$25.76 /

+2.3 (+9.80%)

  • 23
    Apr
Syndicate
Longeveron raises $20.5M in a private placement » 06:56
12/01/21
12/01
06:56
12/01/21
06:56
LGVN

Longeveron

$26.01 /

-0.08 (-0.31%)

Longeveron announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LGVN Longeveron
$26.01 /

-0.08 (-0.31%)

LGVN Longeveron
$26.01 /

-0.08 (-0.31%)

  • 12
    Feb
Recommendations
Zscaler price target raised to $430 from $400 at Deutsche Bank » 06:55
12/01/21
12/01
06:55
12/01/21
06:55
ZS

Zscaler

$347.02 /

-8.795 (-2.47%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

06:49 Today UBS
Zscaler price target raised to $380 from $295 at UBS
06:47 Today Mizuho
Zscaler price target raised to $400 from $385 at Mizuho
06:30 Today BTIG
Zscaler price target raised to $439 from $401 at BTIG
06:14 Today JMP Securities
Zscaler price target raised to $400 from $330 at JMP Securities
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

Recommendations
Salesforce price target lowered to $315 from $330 at UBS » 06:55
12/01/21
12/01
06:55
12/01/21
06:55
CRM

Salesforce

$285.03 /

-11.56 (-3.90%)

UBS analyst Karl…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRM Salesforce
$285.03 /

-11.56 (-3.90%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

06:51 Today Deutsche Bank
Salesforce earnings selloff a buying opportunity, says Deutsche Bank
06:49 Today Mizuho
Salesforce price target lowered to $350 from $360 at Mizuho
11/23/21 BofA
Salesforce price target raised to $360 from $330 at BofA
11/23/21 Jefferies
Salesforce price target raised to $360 from $325 at Jefferies
CRM Salesforce
$285.03 /

-11.56 (-3.90%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

Hot Stocks
Sanofi to acquire Origimm Biotechnology to add ORI-001 to early-stage pipeline » 06:54
12/01/21
12/01
06:54
12/01/21
06:54
SNY

Sanofi

$47.61 /

-0.6 (-1.24%)

Sanofi announced it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$47.61 /

-0.6 (-1.24%)

SNY Sanofi
$47.61 /

-0.6 (-1.24%)

11/01/21 HSBC
Sanofi upgraded to Buy from Hold at HSBC
10/25/21 H.C. Wainwright
Regeneron trial data reinforce bullish outlook on Dupixent, says H.C. Wainwright
10/14/21 JPMorgan
Sanofi price target raised to EUR 105 from EUR 100 at JPMorgan
09/27/21 SVB Leerink
Sanofi upgraded to Outperform at SVB Leerink following pullback
SNY Sanofi
$47.61 /

-0.6 (-1.24%)

SNY Sanofi
$47.61 /

-0.6 (-1.24%)

SNY Sanofi
$47.61 /

-0.6 (-1.24%)

Recommendations
Ambarella price target raised to $155 from $115 at Deutsche Bank » 06:54
12/01/21
12/01
06:54
12/01/21
06:54
AMBA

Ambarella

$180.08 /

-1.835 (-1.01%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

11/29/21 Morgan Stanley
Ambarella price target raised to $222 from $137 at Morgan Stanley
10/27/21 Needham
Ambarella price target raised to $220 from $140 at Needham
10/27/21 Roth Capital
Ambarella price target raised to $225 from $170 at Roth Capital
10/27/21 Stifel
Ambarella price target raised to $200 after Oculii deal at Stifel
AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

Periodicals
23andMe develops immuno-oncology drugs with SPAC cash, WSJ reports » 06:54
12/01/21
12/01
06:54
12/01/21
06:54
ME

23andMe

$8.18 /

-0.67 (-7.57%)

, GSK

GlaxoSmithKline

$41.14 /

-0.225 (-0.54%)

23andMe Holding (ME), the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ME 23andMe
$8.18 /

-0.67 (-7.57%)

GSK GlaxoSmithKline
$41.14 /

-0.225 (-0.54%)

ME 23andMe
$8.18 /

-0.67 (-7.57%)

11/14/21 Citi
23andMe downgraded to Neutral from Buy at Citi
08/16/21 Credit Suisse
23andMe initiated with an Outperform at Credit Suisse
08/16/21 Citi
23andMe price target lowered to $12 from $14 at Citi
07/13/21 Citi
23andMe initiated with a Buy at Citi
GSK GlaxoSmithKline
$41.14 /

-0.225 (-0.54%)

11/30/21 H.C. Wainwright
Vir Biotechnology price target raised to $200 from $135 at H.C. Wainwright
11/24/21 Berenberg
GlaxoSmithKline price target raised to 1,630 GBp from 1,540 GBp at Berenberg
11/08/21 UBS
GlaxoSmithKline price target raised to 1,500 GBp from 1,460 GBp at UBS
11/05/21 Barclays
GlaxoSmithKline upgraded to Equal Weight from Underweight at Barclays
ME 23andMe
$8.18 /

-0.67 (-7.57%)

GSK GlaxoSmithKline
$41.14 /

-0.225 (-0.54%)

GSK GlaxoSmithKline
$41.14 /

-0.225 (-0.54%)

ME 23andMe
$8.18 /

-0.67 (-7.57%)

GSK GlaxoSmithKline
$41.14 /

-0.225 (-0.54%)

ME 23andMe
$8.18 /

-0.67 (-7.57%)

GSK GlaxoSmithKline
$41.14 /

-0.225 (-0.54%)

Recommendations
NetApp price target raised to $92 from $86 at Deutsche Bank » 06:53
12/01/21
12/01
06:53
12/01/21
06:53
NTAP

NetApp

$89.00 /

-2.545 (-2.78%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTAP NetApp
$89.00 /

-2.545 (-2.78%)

NTAP NetApp
$89.00 /

-2.545 (-2.78%)

06:22 Today Citi
Citi cuts HP Enterprise target, opens pair trade with NetApp
11/24/21 Morgan Stanley
Dell Technologies price target raised to $68 from $67 at Morgan Stanley
10/18/21 Goldman Sachs
NetApp downgraded to Sell from Neutral at Goldman Sachs
10/14/21 Citi
NetApp upgraded to Buy from Sell at Citi
NTAP NetApp
$89.00 /

-2.545 (-2.78%)

NTAP NetApp
$89.00 /

-2.545 (-2.78%)

NTAP NetApp
$89.00 /

-2.545 (-2.78%)

Hot Stocks
Roche completes purchase agreement with TIB Molbiol » 06:52
12/01/21
12/01
06:52
12/01/21
06:52
RHHBY

Roche

$48.78 /

+0.45 (+0.93%)

Roche announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$48.78 /

+0.45 (+0.93%)

RHHBY Roche
$48.78 /

+0.45 (+0.93%)

10/21/21 Benchmark
Biogen, Roche calls 'not helpful for Ionis story,' says Benchmark
10/19/21 William Blair
William Blair says Atea MOONSONG results raise concerns, but plunge 'premature'
10/13/21 Morgan Stanley
Roche price target raised to CHF 380 from CHF 370 at Morgan Stanley
09/20/21 Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
RHHBY Roche
$48.78 /

+0.45 (+0.93%)

RHHBY Roche
$48.78 /

+0.45 (+0.93%)

RHHBY Roche
$48.78 /

+0.45 (+0.93%)

Recommendations
GlobalFoundries price target raised to $78 from $75 at Deutsche Bank » 06:52
12/01/21
12/01
06:52
12/01/21
06:52
GFS

GlobalFoundries

$69.42 /

-1.05 (-1.49%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GFS GlobalFoundries
$69.42 /

-1.05 (-1.49%)

GFS GlobalFoundries
$69.42 /

-1.05 (-1.49%)

11/22/21
Fly Intel: Top five analyst initiations
11/22/21 HSBC
GlobalFoundries initiated with a Hold at HSBC
11/22/21 BofA
BofA starts GlobalFoundries at Buy, sees 40% upside potential
11/22/21 JPMorgan
GlobalFoundries initiated with an Overweight at JPMorgan
GFS GlobalFoundries
$69.42 /

-1.05 (-1.49%)

  • 28
    Oct
GFS GlobalFoundries
$69.42 /

-1.05 (-1.49%)

GFS GlobalFoundries
$69.42 /

-1.05 (-1.49%)

Hot Stocks
Northern Dynasty comments on EPA press release regarding Pebble Project » 06:52
12/01/21
12/01
06:52
12/01/21
06:52
NAK

Northern Dynasty

/

+

Northern Dynasty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NAK Northern Dynasty
/

+

NAK Northern Dynasty
/

+

02/11/21 H.C. Wainwright
Northern Dynasty price target raised to $1.20 from 80c at H.C. Wainwright
12/04/20 H.C. Wainwright
Northern Dynasty price target lowered to 80c from $3.25 at H.C. Wainwright
NAK Northern Dynasty
/

+

Recommendations
Salesforce earnings selloff a buying opportunity, says Deutsche Bank » 06:51
12/01/21
12/01
06:51
12/01/21
06:51
CRM

Salesforce

$285.03 /

-11.56 (-3.90%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRM Salesforce
$285.03 /

-11.56 (-3.90%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

06:49 Today Mizuho
Salesforce price target lowered to $350 from $360 at Mizuho
11/23/21 BofA
Salesforce price target raised to $360 from $330 at BofA
11/23/21 Jefferies
Salesforce price target raised to $360 from $325 at Jefferies
11/23/21 Citi
Salesforce price target raised to $308 from $280 at Citi
CRM Salesforce
$285.03 /

-11.56 (-3.90%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

Hot Stocks
China Finance Online appoints CEO Bin Zhang as independent director » 06:50
12/01/21
12/01
06:50
12/01/21
06:50
JRJC

China Finance Online

$6.56 /

-0.06 (-0.91%)

China Finance Online…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JRJC China Finance Online
$6.56 /

-0.06 (-0.91%)

Hot Stocks
Merck: FDA accepts for priority review sBLA for VAXNEUVANCE » 06:50
12/01/21
12/01
06:50
12/01/21
06:50
MRK

Merck

$74.87 /

-0.005 (-0.01%)

Merck announced the U.S.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$74.87 /

-0.005 (-0.01%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

11/29/21
Fly Intel: Top five analyst downgrades
11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 Citi
Merck downgraded to Neutral from Buy at Citi
MRK Merck
$74.87 /

-0.005 (-0.01%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

Recommendations
Zscaler price target raised to $380 from $295 at UBS » 06:49
12/01/21
12/01
06:49
12/01/21
06:49
ZS

Zscaler

$347.02 /

-8.795 (-2.47%)

UBS analyst Roger Boyd…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

06:47 Today Mizuho
Zscaler price target raised to $400 from $385 at Mizuho
06:30 Today BTIG
Zscaler price target raised to $439 from $401 at BTIG
06:14 Today JMP Securities
Zscaler price target raised to $400 from $330 at JMP Securities
06:03 Today Piper Sandler
Zscaler price target raised to $365 from $285 at Piper Sandler
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

Recommendations
Salesforce price target lowered to $350 from $360 at Mizuho » 06:49
12/01/21
12/01
06:49
12/01/21
06:49
CRM

Salesforce

$285.03 /

-11.56 (-3.90%)

Mizuho analyst Gregg…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRM Salesforce
$285.03 /

-11.56 (-3.90%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

11/23/21 BofA
Salesforce price target raised to $360 from $330 at BofA
11/23/21 Jefferies
Salesforce price target raised to $360 from $325 at Jefferies
11/23/21 Citi
Salesforce price target raised to $308 from $280 at Citi
11/22/21 Atlantic Equities
Atlantic Equities assumes 'low-risk' Salesforce at Overweight
CRM Salesforce
$285.03 /

-11.56 (-3.90%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

Earnings
Philip Morris sees FY21 adjusted EPS, currency only $5.98-$6.03, consensus $6.08 » 06:48
12/01/21
12/01
06:48
12/01/21
06:48
PM

Philip Morris

$85.98 /

-1.37 (-1.57%)

Representing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PM Philip Morris
$85.98 /

-1.37 (-1.57%)

PM Philip Morris
$85.98 /

-1.37 (-1.57%)

11/29/21 Barclays
Philip Morris price target lowered to $113 from $116 at Barclays
09/30/21 Stifel
Stifel surprised and 'disappointed' by ITC banning IQOS importation
09/30/21 BofA
Altria, Philip Morris still well positioned despite IQOS 'setback,' says BofA
09/13/21 Stifel
Altria could trade down on news of Democrats' proposal, says Stifel
PM Philip Morris
$85.98 /

-1.37 (-1.57%)

PM Philip Morris
$85.98 /

-1.37 (-1.57%)

PM Philip Morris
$85.98 /

-1.37 (-1.57%)

Hot Stocks
Thor Industries promotes Todd Woelfer to COO, Trevor Gasper to general counsel » 06:48
12/01/21
12/01
06:48
12/01/21
06:48
THO

Thor Industries

$106.02 /

+0.62 (+0.59%)

Thor Industries announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
THO Thor Industries
$106.02 /

+0.62 (+0.59%)

THO Thor Industries
$106.02 /

+0.62 (+0.59%)

10/25/21 KeyBanc
Thor downgraded to Sector Weight on 'waning demand' at KeyBanc
10/25/21 KeyBanc
Thor Industries downgraded to Sector Weight from Overweight at KeyBanc
10/01/21 BMO Capital
Winnebago price target raised to $100 from $90 at BMO Capital
09/29/21 Truist
Thor Industries price target raised to $142 from $130 at Truist
THO Thor Industries
$106.02 /

+0.62 (+0.59%)

THO Thor Industries
$106.02 /

+0.62 (+0.59%)

Recommendations
Zscaler price target raised to $400 from $385 at Mizuho » 06:47
12/01/21
12/01
06:47
12/01/21
06:47
ZS

Zscaler

$347.02 /

-8.795 (-2.47%)

Mizuho analyst Gregg…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

06:30 Today BTIG
Zscaler price target raised to $439 from $401 at BTIG
06:14 Today JMP Securities
Zscaler price target raised to $400 from $330 at JMP Securities
06:03 Today Piper Sandler
Zscaler price target raised to $365 from $285 at Piper Sandler
11/29/21 Needham
Zscaler price target raised to $390 from $345 at Needham
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

Hot Stocks
Sanofi confirms Vaccines mid-term view of mid-to-high single-digit sales growth » 06:47
12/01/21
12/01
06:47
12/01/21
06:47
SNY

Sanofi

$47.61 /

-0.6 (-1.24%)

Sanofi will host a hybrid…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$47.61 /

-0.6 (-1.24%)

SNY Sanofi
$47.61 /

-0.6 (-1.24%)

11/01/21 HSBC
Sanofi upgraded to Buy from Hold at HSBC
10/25/21 H.C. Wainwright
Regeneron trial data reinforce bullish outlook on Dupixent, says H.C. Wainwright
10/14/21 JPMorgan
Sanofi price target raised to EUR 105 from EUR 100 at JPMorgan
09/27/21 SVB Leerink
Sanofi upgraded to Outperform at SVB Leerink following pullback
SNY Sanofi
$47.61 /

-0.6 (-1.24%)

SNY Sanofi
$47.61 /

-0.6 (-1.24%)

SNY Sanofi
$47.61 /

-0.6 (-1.24%)

Recommendations
Cytokinetics price target raised to $54 from $45 at Mizuho » 06:46
12/01/21
12/01
06:46
12/01/21
06:46
CYTK

Cytokinetics

$39.30 /

+0.51 (+1.31%)

Mizuho analyst Salim Syed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CYTK Cytokinetics
$39.30 /

+0.51 (+1.31%)

CYTK Cytokinetics
$39.30 /

+0.51 (+1.31%)

11/04/21 H.C. Wainwright
Cytokinetics price target raised to $62 from $58 at H.C. Wainwright
10/12/21 Cantor Fitzgerald
Cytokinetics price target raised to $57 from $48 at Cantor Fitzgerald
10/06/21 Jefferies
Cytokinetics initiated with a Buy at Jefferies
10/04/21 Piper Sandler
Cytokinetics set to make commercial impact, says Piper Sandler
CYTK Cytokinetics
$39.30 /

+0.51 (+1.31%)

  • 21
    Jul
CYTK Cytokinetics
$39.30 /

+0.51 (+1.31%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.